ASS1P13

Across TCGA pan-cancer cohorts, ASS1P13 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated ASS1P13 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ASS1P13 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ASS1P13 expression acts as an unfavorable survival marker, although some lineages such as KIRC and CESC show a favorable association.

UCEC, KIRC, and CESC are the cancer types where ASS1P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.524	0.805	<.001	80	view →
KIRC	DFS	Tertile	III,IV	0.895	0.661	.003	38	view →
CESC	DFS	Quartile	II,III,IV	0.914	0.346	<.001	28	view →
HNSC	DFS	Median	All	0.445	0.635	.008	20	view →
LUAD	DFS	Quartile	All	0.718	0.352	<.001	18	view →
COAD	OS	Tertile	IV	0.282	0.896	.014	17	view →
CHOL	DFS	Median	III,IV	0.133	0.779	.038	9	view →
GBM	OS	Tertile	All	0.494	0.336	.014	6	view →
ESCA	OS	Quartile	All	0.464	1.000	.037	6	view →
KIRP	DFS	Tertile	II,III,IV	1.000	0.602	.033	6	view →
PRAD	DFS	Tertile	All	0.840	0.924	.018	6	view →
READ	OS	Median	IV	0.455	0.824	.005	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

ASS1P13–UCEC (OS)

Open the UCEC breakdown →